Brazil’s Cancer Statistics
704,000 new cases of cancer are expected for the triennium 2023-2025. Except for non-melanoma skin cancer, 483,000 new cases will occur. Female breast cancer and prostate cancer were the most frequent with 73,000 and 71,000 new cases, respectively, followed by colorectal cancer (45,000), lung (32,000) and stomach (21,000), and cervical cancer (17,000).
In Brazil, due to its continental dimensions and heterogeneity both in terms of population and territory, the incidence profile reflects the diversity of geographic regions, and patterns similar to developed and developing countries.
Estimated Cancer Incidence in Brazil, 2023-2025 doi: https://doi.org/10.32635/2176-9745.RBC.2023v69n1.3700
Lymphoma
There were 70,850 lymphoma cases between 2008 and 2017, of which 55% were male, the median age was 51 years, and 27% had Hodgkin Lymphoma. Most patients (56%) were treated outside the residence city. São Paulo State accounted for 25% of patients. Treatment initiation took more than 60 days in 27% of cases. A total of 45,601 deaths were due to lymphoma (12% Hodgkin Lymphoma and 88% Non-Hodgkin Lymphoma), with a median age 63 years, and were mainly males (55%). Staging data were inadequate in 23% of patients, and analysis was performed only on the valid records. Advanced disease was diagnosed in 58% of patients (60% male; 57% female) and was more common in Non-Hodgkin Lymphoma (62%) versus Hodgkin Lymphoma (49%). (Hematol Transfus Cell Ther. 2022 Jan-Mar; 44(1): 40–48.)
Breast Cancer
Apart from non-melanoma skin cancer, breast cancer is the most common cancer among women in Brazil, followed by colorectal and cervical cancers. In Brazil, 73 610 new breast cancer cases are expected each year from 2023 to 2025, representing an adjusted incidence rate of 41·89 cases per 100 000 women. (The Lancet)
Colorectal Cancer
In Brazil, it is the second most frequent cancer in men and women, with a mortality reaching 9.4% of those diagnosed. (PLoS One. 2023; 18(7): e0288241.)